Uveitis
Conditions
Interventions
Experimental group A:Dexamethasone vitreous implant (Odx) 0.7mg intravitreal injection
Experimental group B:The Tenon capsule was injected with triamcinolone acetonide
Control group:Ophthalmic topical and oral medications
Sponsors
Nanning Aier Eye Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with non-infectious uveitis.
Exclusion criteria
Exclusion criteria: 1. Using other immunosuppressants or cytotoxic drugs; 2. Patients with hypertension, diabetes or any type of cancer; 3. Complicated with hepatitis, pneumonia, pyelonephritis, herpes zoster or received live vaccine within the last 3 months; 4. A history of tuberculosis, human immunodeficiency virus, AIDS or opportunistic infections; 5. Female patients who were pregnant, breast-feeding or of childbearing age during the study period; 6. Those who fail to make regular reexamination and refuse to cooperate with drug guidance; 7. Incomplete clinical data; 8. Poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Best-corrected visual acuity;Macular thickness;Intraocular pressure and macular edema resolution;Whether complications such as epimacular membrane occur; | — |
Countries
China
Contacts
Public ContactOu Zuguo
Nanning Aier Eye Hospital
Outcome results
None listed